Drug Type siRNA |
Synonyms KHK siRNA(Boehringer Ingelheim), KHK 1334, KHK1334 |
Target |
Action inhibitors |
Mechanism KHK inhibitors(Ketohexokinase inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |



| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | Germany | 03 Nov 2023 | |
| Metabolic dysfunction-associated steatotic liver disease | Preclinical | Germany | 03 Nov 2023 |





